BIOKIN PHARMACEUTICAL

Unusual Whales · Jul 17 at 07:27 AM

SystImmune Announces Second Approval of Iza-bren in China for the Treatment of Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Yicai · Jun 23 at 01:26 AM

China’s Biokin Soars After Its First-in-Class Cancer Drug Is Greenlit for Chinese Market Launch

prnewswire · Jun 22 at 02:09 PM

15:07 ETSystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China

Wallstreetcn · Mar 31 at 09:07 PM

Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

Wallstreetcn · Mar 25 at 08:41 PM

Highest 1-Year OS Rate! iza-bren Combined with Sintilimab Achieves 8.2 Months mPFS and 85.7% 1-Year OS Rate in First-Line Extensive-Stage Small Cell Lung Cancer

Simplywall · Feb 28 at 06:21 PM

Bristol-Myers Squibb Cancer Advances Test Valuation Gap For Investors